LDLR combined and IL28B for predicting response to treatment with pegylated interferon plus ribavirin in patients infected with hepatitis C virus genetic polymorphisms

摘要

The use of genetic polymorphisms rs2738456, rs2738457, rs2569540, rs2738459, rs2738460, rs2l16898, and rs6413504 LDLR gene to predict or forecast the response to treatment with pegylated interferon plus ribavirin in patients infected with HCV.